Papers and Presentations
How to Search for Resources
You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.
Refine Results
Filter By Resource Type
Filter By Event Types
- WCBP (461)
- Cell & Gene Therapy Products (189)
- CE Pharm (187)
- Mass Spectrometry (173)
- CMC Strategy Forum Europe (157)
- Bioassays (134)
- Higher Order Structure (109)
- AT Europe (109)
- CMC Strategy Forum Japan (105)
- CMC Strategy Forum (78)
- CMC Strategy Forum North America Winter (77)
- CMC Strategy Forum North America Summer (61)
- CMC Strategy Forum Latin America (40)
- CGTP Summit (29)
- CMC Strategy Forum China (29)
- CMC Strategy Forum North America Fall (14)
- Consultants' Network (12)
- CGTP Europe (11)
- Symposium on mRNA (11)
- Virtual Summit: Manufacturing (8)
- Biophysics Working Group (8)
- Virtual Europe Discussion Group (8)
- CGTP Virtual Summit (7)
- NorCal Regional Forum (6)
- Netherlands Area Biotech Discussion Group (5)
- DC Area Scientific Discussion Group (4)
- Biotech Working Group (2)
- Midwest Regional Forum (2)
- CMC-Vaccines Working Group (1)
Filter By Tags
-
Code, Care, and Conscience: How AI, Ethics, and Lived Experience Are Redefining the Future of Pharma
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/wcbp/wcbp_120x120_landing.jpg?sfvrsn=64c6446d_1)
Speaker Presentation: WCBP 2026 Hayes-Mota Guadalupe, Santa Clara University, 2026 -
Side-by-Side Stress Studies Designed to Support Post-Change Shelf Life
Speaker Presentation: WCBP 2026 Flick Tawnya, Gilead Sciences, Inc., 2026
-
International Collaboration and Reliance
Speaker Presentation: WCBP 2026 Dooley Brian, European Medicines Agency, 2026
-
Insights to Industry Led CMC PAC Reliance Pilots on Behalf of EFPIA
Speaker Presentation: WCBP 2026 Ban Cynthia, Sanofi Pasteur Limited Canada, 2026
-
Keynote Session III - The Heart of Innovation: Patients Shaping the Future of Biologics
Speaker Presentation: WCBP 2026Abernathy Michael, Amgen Inc., 2026
-
30th Anniversary Workshop: Pet Peeves and Roadblocks in CMC: Improving your Quality Submissions through the Product Lifecycle Redux – The 2026 Version
Speaker Presentation: WCBP 2026Marjorie Shapiro, Chana Fuchs, 2026
-
Vaccine Specific Regulatory Considerations
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/wcbp/2023/wcbp_120x120_landing.jpg?sfvrsn=40f36ee0_3)
Roundtable Notes: Session 2 Table 9 WCBP 2026 Vaccine Specific Regulatory Considerations -
Vaccine Potency - Compare and Contrast Potency Tests for Different Vaccine Modalities
Roundtable Notes: Session 2 Table 2 WCBP 2026Vaccine Potency - Compare and Contrast Potency Tests for …
-
Using Accelerated Degradation Studies to Support Comparability Assessments
Roundtable Notes: Session 2 Table 13 WCBP 2026Using Accelerated Degradation Studies to Support Comparability …
-
Use of Machine Learning (ML) and Artificial Intelligence (AI) in Content Creation of Early Phase Development and Managing Submissions and Information Requests with Health Authorities
Roundtable Notes: Session 1 Table 16 WCBP 2026Use of Machine Learning (ML) and Artificial Intelligence …
-
Use of Chromatography Resins Across Multiple Products
Roundtable Notes: Session 1 Table 11 WCBP 2026Use of Chromatography Resins Across Multiple Products
-
Use of Artificial Intelligence for Process and Analytical Method Development
Roundtable Notes: Session 2 Table 12 WCBP 2026Use of Artificial Intelligence for Process and Analytical …
-
Strategies for Leveraging Clinical Stability Data for Commercial Shelf Life
Roundtable Notes: Session 1 Table 15 WCBP 2026Strategies for Leveraging Clinical Stability Data for Commercial …
-
Speed to Clinic - Phase-Appropriate Strategies to Accelerate CMC Development Timelines
Roundtable Notes: Session 1 Table 4 WCBP 2026Speed to Clinic - Phase-Appropriate Strategies to Accelerate …
-
Recent Trends in Questions from Health Authorities [Session 2]
Roundtable Notes: Session 2 Table 1 WCBP 2026Recent Trends in Questions from Health Authorities [Session …
-
Recent Trends in Questions from Health Authorities [Session 1]
Roundtable Notes: Session 1 Table 1 WCBP 2026Recent Trends in Questions from Health Authorities [Session …
-
Novel Applications of Molecular and Structural Biology in Characterization of Well Characterized Biologics
Roundtable Notes: Session 1 Table 3 WCBP 2026Novel Applications of Molecular and Structural Biology in …
-
Novel Applications of Molecular and Structural Biology in Characterization of ATMPS
Roundtable Notes: Session 2 Table 3 WCBP 2026Novel Applications of Molecular and Structural Biology in …
-
In-Use Studies - Compatibility and Stability Studies
Roundtable Notes: Session 2 Table 17 WCBP 2026In-Use Studies - Compatibility and Stability Studies
-
Interpreting Confidence Intervals in Analytical Validation under ICH Q2(R2): From Statistical Reporting to Decision-Making
Roundtable Notes: Session 2 Table 11 WCBP 2026Interpreting Confidence Intervals in Analytical Validation …